Skip to content

Ultrasound Guided Intermediate Cervical Plexus Block in Thyroid Surgery

Effect of Dexmethasone Addition to Bupivacaine in Bilateral Intermediate Cervical Block in Thyroid Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03731468
Enrollment
60
Registered
2018-11-06
Start date
2018-09-15
Completion date
2020-12-01
Last updated
2021-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Brief summary

studying the effect of dexmeditomidine addition to bupivacaine in bilateral intermediate cervical block for patients undergoing thyroidectomy under general anaesthesia

Detailed description

80 patients who will be undergoing elective thyroidectomy will be randomly allocated into one of two groups ; group A will receive 20 mg isobaric bupivacaine + 8 mg dexamethasone(diluted in 5 ml) group B will receive 20 mg isobaric bupivacaine + 1 ml normal saline. block will be done under complete a septic condition after induction of general anaesthesia.

Interventions

DRUGlocal anesthetic

ultrasound guided superficial cervical block in thyroid surgery

DRUGDexamethasone

dexamethasone will be added to ultrasound guided superficial cervical block in thyroid surgery

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Elective surgery * ASA 1, II, AND III

Exclusion criteria

* Patient refusal * Infection at the entry site * BMI \> 3

Design outcomes

Primary

MeasureTime frameDescription
postoperative analgesia duration24 hour postoperativetime of first analgesic requirement is the time of end of block analgesia

Secondary

MeasureTime frameDescription
postoperative complications related to the block8 hoursoccurrence of complications secondary to the block well be recorded

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026